{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:48:56Z","timestamp":1790686136988,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1097\/wco.0b013e32832c4ff5","type":"journal-article","created":{"date-parts":[[2010,3,9]],"date-time":"2010-03-09T02:39:10Z","timestamp":1268102350000},"page":"189-193","source":"Crossref","is-referenced-by-count":32,"title":["Tuberous sclerosis complex: a brave new world?"],"prefix":"10.1097","volume":"23","author":[{"given":"Kevin C","family":"Ess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210206","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"R2-17-20210206","first-page":"81","article-title":"Tuberous sclerosis with cortical abnormalities: mental retardation and hemiplegic epilepsy","volume":"1","author":"Bourneville","year":"1880","journal-title":"Archives de neurologie"},{"key":"R3-17-20210206","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"R4-17-20210206","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16.","volume":"75","author":"Consortium","year":"1993","journal-title":"Cell"},{"key":"R5-17-20210206","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.ejhg.5201402","article-title":"Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype\u2013phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex","volume":"13","author":"Sancak","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"R6-17-20210206","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R7-17-20210206","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1054\/bjoc.2001.2072","article-title":"Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas","volume":"85","author":"Parry","year":"2001","journal-title":"Br J Cancer"},{"key":"R8-17-20210206","first-page":"400","article-title":"Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions","volume":"59","author":"Henske","year":"1996","journal-title":"Am J Hum Genet"},{"key":"R9-17-20210206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1470-2045(07)70411-4","article-title":"Possible mechanisms of disease development in tuberous sclerosis","volume":"9","author":"Jozwiak","year":"2008","journal-title":"Lancet Oncol"},{"key":"R11-17-20210206","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1177\/08830738040190090801","article-title":"Managing epilepsy in tuberous sclerosis complex","volume":"19","author":"Thiele","year":"2004","journal-title":"J Child Neurol"},{"key":"R12-17-20210206","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.57.8.1416","article-title":"Randomized trial of vigabatrin in patients with infantile spasms","volume":"57","author":"Elterman","year":"2001","journal-title":"Neurology"},{"key":"R13-17-20210206","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1528-1167.2008.01788.x","article-title":"Infantile spasms in tuberous sclerosis complex: prognostic utility of EEG","volume":"50","author":"Muzykewicz","year":"2009","journal-title":"Epilepsia"},{"key":"R14-17-20210206","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4161\/cbt.2.5.446","article-title":"Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis","volume":"2","author":"Kwiatkowski","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"R15-17-20210206","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1081\/CNV-200027144","article-title":"The tuberous sclerosis complex genes in tumor development","volume":"22","author":"Mak","year":"2004","journal-title":"Cancer Invest"},{"key":"R16-17-20210206","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"R17-17-20210206","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/MCB.00289-08","article-title":"The TSC1-TSC2 complex is required for proper activation of mTOR complex 2","volume":"28","author":"Huang","year":"2008","journal-title":"Mol Cell Biol"},{"key":"R18-17-20210206","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1073\/pnas.151033798","article-title":"A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice","volume":"98","author":"Kobayashi","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-17-20210206","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1172\/JCI7319","article-title":"Tsc2(+\/\u2212) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background","volume":"104","author":"Onda","year":"1999","journal-title":"J Clin Invest"},{"key":"R20-17-20210206","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1038\/sj.onc.1205435","article-title":"Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+\/\u2212 cells","volume":"21","author":"Uhlmann","year":"2002","journal-title":"Oncogene"},{"key":"R21-17-20210206","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.10283","article-title":"Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures","volume":"52","author":"Uhlmann","year":"2002","journal-title":"Ann Neurol"},{"key":"R22-17-20210206","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","article-title":"A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival","volume":"27","author":"Meikle","year":"2007","journal-title":"J Neurosci"},{"key":"R23-17-20210206","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ana.10648","article-title":"Impaired glial glutamate transport in a mouse tuberous sclerosis epilepsy model","volume":"54","author":"Wong","year":"2003","journal-title":"Ann Neurol"},{"key":"R24-17-20210206","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1528-1167.2005.00289.x","article-title":"Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes","volume":"46","author":"Jansen","year":"2005","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"R25-17-20210206","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1528-1167.2008.01493.x","article-title":"Tuberous sclerosis: a primary pathology of astrocytes?","volume":"49","author":"Sosunov","year":"2008","journal-title":"Epilepsia"},{"key":"R26-17-20210206","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J Neurosci"},{"key":"R27-17-20210206","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1788","article-title":"Reversal of learning deficits in a Tsc2+\/\u2212 mouse model of tuberous sclerosis","volume":"14","author":"Ehninger","year":"2008","journal-title":"Nat Med"},{"key":"R28-17-20210206","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.21058","article-title":"Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1","volume":"61","author":"Wang","year":"2007","journal-title":"Ann Neurol"},{"key":"R29-17-20210206","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"R30-17-20210206","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.21317","article-title":"Cognitive deficits in Tsc1+\/\u2212 mice in the absence of cerebral lesions and seizures","volume":"62","author":"Goorden","year":"2007","journal-title":"Ann Neurol"},{"key":"R31-17-20210206","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","article-title":"Rapamycin causes regression of astrocytomas in tuberous sclerosis complex","volume":"59","author":"Franz","year":"2006","journal-title":"Ann Neurol"},{"key":"R32-17-20210206","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1177\/0883073808321764","article-title":"Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex","volume":"23","author":"Koenig","year":"2008","journal-title":"J Child Neurol"},{"key":"R33-17-20210206","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"R34-17-20210206","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1056\/NEJMc072500","article-title":"Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis","volume":"358","author":"Davies","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e32832c4ff5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:20:58Z","timestamp":1786040458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-201004000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e32832c4ff5","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}